(Q44580662)

English

Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates

scientific article published in September 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

David Ritterband

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Regis P Kowalski

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Deepinder K Dhaliwal

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Lisa M Karenchak

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Eric G Romanowski

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Francis S Mah

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Y Jerold Gordon

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

American Journal of Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

136

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

500-505

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900294-0

7 January 2021

Emerging ciprofloxacin-resistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900294-0

7 January 2021

Fluoroquinolone resistance among Gram-positive cocci

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900294-0

7 January 2021

Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900294-0

7 January 2021

Mechanism of quinolone resistance in Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900294-0

7 January 2021

Mechanisms of fluoroquinolone resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900294-0

7 January 2021

Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900294-0

7 January 2021

An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900294-0

7 January 2021

Identifiers

10.1016/S0002-9394(03)00294-0

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44580662&oldid=2028619707"